Literature DB >> 6694382

Acid and isoproterenol cause serotonin release by acting on opposite surfaces of duodenal mucosa.

J M Kellum, M Donowitz, A Cerel, J Wu.   

Abstract

Although most bodily serotonin (5-HT) is stored in intestinal enterochromaffin (EC) cells, the mechanism of its release is only now being elucidated. It has previously been reported that such stimuli as luminal acidification or exposure of both sides of a rabbit duodenal mucosal sheet to certain autonomic agonists stimulate release from the mucosal surface in the Ussing chamber model. The hypothesis in the present study is that acid acts only on the mucosal surface, whereas neural receptor agonists and antagonists act specifically on the serosal surface, as would be predicted by the location of acid in the gut lumen and nerve terminals at the bases of the EC cells. 5-HT release was measured by radioimmunoassay from the mucosal surface bathing solution. Duodenal mucosal sheets were exposed separately on the mucosal or serosal surfaces to acid (citric phosphate buffer, pH 5) or to isoproterenol (10(-5) M). The effect of atropine (10(-6) M) and propranolol (10(-6) M) on acid-stimulated mucosal release was studied by combining luminal acid stimulation with one of these antagonists, on either the mucosal or serosal surface. The results demonstrate significant (P less than 0.01) mucosal serotonin release (56 +/- 9 ng cm-2 hr-1) only with mucosal acidification. On the other hand, isoproterenol causes significant (P less than 0.05) serotonin release (12.4 +/- 3 ng cm-2 hr-1) only when introduced onto the serosal surface. Finally, the antagonists, atropine and propranolol, blocked acid-stimulated serotonin release only when added to the serosal surface. Since acid-induced serotonin release has been shown to be partially mediated by cholinergic and beta-adrenergic mechanisms, these findings suggest interconnection of mucosal acid receptors with submucosal neurons which mediate serotonin release by acting on the basal surface of the enterochromaffin cell.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6694382     DOI: 10.1016/0022-4804(84)90084-2

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  5 in total

1.  Selective inhibition of intestinal 5-HT improves neurobehavioral abnormalities caused by high-fat diet mice.

Authors:  Qi Pan; Qiongzhen Liu; Renling Wan; Praveen Kumar Kalavagunta; Li Liu; Wenting Lv; Tong Qiao; Jing Shang; Huali Wu
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

Review 2.  Duodenal Chemosensing of Short-Chain Fatty Acids: Implications for GI Diseases.

Authors:  Mari Iwasaki; Yasutada Akiba; Jonathan D Kaunitz
Journal:  Curr Gastroenterol Rep       Date:  2019-07-10

3.  FFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.

Authors:  Yasutada Akiba; Koji Maruta; Kazuyuki Narimatsu; Hyder Said; Izumi Kaji; Ayaka Kuri; Ken-Ichi Iwamoto; Atsukazu Kuwahara; Jonathan D Kaunitz
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-05-19       Impact factor: 4.052

4.  Effects of intravenous calcium on release of serotonin into jejunal lumen and portal circulation.

Authors:  S R Money; K Kimura; A Petroianu; B M Jaffe
Journal:  Dig Dis Sci       Date:  1988-08       Impact factor: 3.199

5.  Intraluminal release of serotonin, substance P, and gastrin in the canine small intestine.

Authors:  A Ferrara; M J Zinner; B M Jaffe
Journal:  Dig Dis Sci       Date:  1987-03       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.